Vaidya Sane Ayurved Laboratories Ltd

₹ 155 -5.00%
30 Jun - close price
About

Vaidya Sane Ayurved Laboratories Ltd is engaged in treatment of chronic ailments like cardiac disease, diabetes, hypertension and obesity through innovative therapies primarily developed through Ayurveda.[1]

Key Points

Clinics Network
As per Jan 2022, the company operates ~274 clinics out of which 52 are company owned and the rest are franchise clinics. It also owns 2 cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur respectively.[1]

  • Market Cap 163 Cr.
  • Current Price 155
  • High / Low 249 / 98.0
  • Stock P/E 46.6
  • Book Value 34.1
  • Dividend Yield 0.00 %
  • ROCE 22.6 %
  • ROE 15.3 %
  • Face Value 10.0

Pros

  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 9.57% for last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2021 Mar 2022
31.56 43.15
28.95 38.87
Operating Profit 2.61 4.28
OPM % 8.27% 9.92%
0.00 0.34
Interest 0.11 0.09
Depreciation 1.17 1.11
Profit before tax 1.33 3.42
Tax % -2.26% 38.30%
Net Profit 1.35 2.11
EPS in Rs 1.94 2.01

Profit & Loss

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022
62.30 74.61 52.01 74.24
59.20 71.70 47.54 66.90
Operating Profit 3.10 2.91 4.47 7.34
OPM % 4.98% 3.90% 8.59% 9.89%
0.07 0.07 -1.06 0.32
Interest 0.70 1.20 0.51 0.63
Depreciation 1.59 2.23 2.45 2.29
Profit before tax 0.88 -0.45 0.45 4.74
Tax % 44.32% -24.44% 15.56% 27.00%
Net Profit 0.50 -0.56 0.39 3.47
EPS in Rs 111.11 -124.44 86.67 3.30
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 6%
TTM: 43%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 91%
TTM: 275%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 10%
Last Year: 15%

Balance Sheet

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022
0.05 0.05 0.05 10.51
Reserves 8.74 8.17 9.72 25.37
8.67 5.97 1.02 1.06
11.41 14.93 15.02 14.81
Total Liabilities 28.87 29.12 25.81 51.75
15.66 15.51 17.16 17.01
CWIP 2.02 3.79 0.38 1.23
Investments 0.02 0.02 0.01 4.88
11.17 9.80 8.26 28.63
Total Assets 28.87 29.12 25.81 51.75

Cash Flows

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022
1.58 7.72 5.77 -13.12
-10.05 -3.93 -0.67 -7.71
7.71 -3.63 -5.26 22.49
Net Cash Flow -0.77 0.16 -0.16 1.66

Ratios

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 21.38 12.23 18.53 17.50
Inventory Days 76.92 49.49 35.00 24.82
Days Payable 137.65 138.39 146.74 122.11
Cash Conversion Cycle -39.34 -76.67 -93.21 -79.79
Working Capital Days -7.15 -26.07 -46.39 56.34
ROCE % 4.74% 16.97% 22.59%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents